Cosela Injection, Powder, Lyophilized, For Solution
Product Images NDC 73462-101

3 FDA label images from G1 Therapeutics, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cosela (NDC 73462-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by G1 Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cos07 0004 01)

Chemical Structure (Cos07 0004 01)
Chemical structure diagram of trilaciclib, the active ingredient in COSELA injection, showing its molecular framework with labeled atoms and bonds.*
FDA Label Image

Principal Display Panel – 300 mg Carton Label (Cos07 0004 02)

Principal Display Panel – 300 mg Carton Label (Cos07 0004 02)
The packaging label for COSELA (trilaciclib) injection displays the product as a 300 mg vial of lyophilized powder for intravenous infusion after reconstitution and dilution. Distributed by G1 Therapeutics, Inc., the label includes dosage preparation instructions, storage conditions, and a barcode. The label emphasizes it is for single-dose use and specifies the vial contents and stability information.*
FDA Label Image

Principal Display Panel – 300 mg Vial Label (Cos07 0004 03)

Principal Display Panel – 300 mg Vial Label (Cos07 0004 03)
Label for Cosela (trilaciclib) for injection, 300 mg per vial, lyophilized powder for intravenous infusion after reconstitution and dilution. The label includes usage instructions, storage conditions, and distributor information for G1 Therapeutics, Inc., Durham, NC. Product of Finland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.